Allicin protects against hepatic ischemia/reperfusion injury via PPARγ/Interleukin-1 receptor-associated kinase-M (IRAK-M)/Toll-like receptor 4 (TLR4) signaling pathway (Li W. et al., 2022). The gene discussed is TLR4; the disease is ischemia.